FIND in the news

Year: Program:

Links to news items can only be guaranteed on date of publication.


Bioresearch Online, 25 March 2014

New tests can diagnose TB within two hours, while older diagnostic tests could take as long as three months to produce an accurate result. The WHO partnered with the Foundation for Innovative New Diagnostics for the Expand-TB project. The Foundation will provide screening technology to middle and low income countries affected by TB.

Scientific American, 24 March 2014

For example, non-profits such as the Foundation for Innovative New Diagnostics, the TB Alliance and Aeras have recently established themselves as key global participants in the pursuit of new TB diagnostics, drugs and vaccines, respectively.

All Africa, 21 March 2014

The machine is small about the size of a microwave oven and can fit easily on a small table. It was developed in the United States by a company called Cepheid and an organisation called the Foundation for Innovative New Diagnostics (FIND), supported by the American National Institutes of Health.

New Vision - Uganda, 20 March 2014

According to Dr. Charles Wamboga, the in-charge of sleeping sickness at the ministry of health, the break has come as a result of intensive suppression methods supported by different stakeholders. “To sustain this reduction, government with support from Foundation for Innovative New Diagnostics (FIND), is strengthening case detection for sleeping sickness in the north-west region,” he said. He said further that the partnership caused the increase of diagnostic centres in West Nile from four to 200 centres while FIND plans to expand services to South Sudan in order to stop re-infestation as the tsetse fly is trans-boundary in nature. “Given the severity and fatality associated with sleeping sickness, there is still need to continue surveillance efforts,” warned Wamboga

Med-Tech Innovation, 03 January 2014

Patients may not stay in one place very long Patients can include a large proportion of transitory or dispersed populations with no formal ID or address, which means fast turnarounds and good sample tracking are essential. For example, one of the main drivers for a new Malaria screening test, developed by the Foundation for Innovative New Diagnostics (, is use of localised high throughput processing in the field. Samples are collected, tested and treatment is issued within one day to ensure the best chance of finding positive patients again. GPS tracking is also increasingly used during sample collection to log the patient’s exact location (typically in their home) and enabling them to be more easily located for treatment; the technology is also invaluable in monitoring the geographical spread of disease.